빅테그라비르/엠트리시타빈/테노포비르 알라페나미드

ko

WikiRank.net
ver. 1.6

빅테그라비르/엠트리시타빈/테노포비르 알라페나미드

Quality:

Bictegravir/emtricitabine/tenofovir alafenamide - fixed dose combination drug. Article "빅테그라비르/엠트리시타빈/테노포비르 알라페나미드" in Korean Wikipedia has 30.3 points for quality (as of July 1, 2025). The article contains 17 references and 6 sections.

This article has the best quality in English Wikipedia. Also, this article is the most popular in that language version.

Since the creation of article "빅테그라비르/엠트리시타빈/테노포비르 알라페나미드", its content was written by 6 registered users of Korean Wikipedia and edited by 39 registered Wikipedia users in all languages.

The article is cited 58 times in Korean Wikipedia and cited 233 times in all languages.

The highest Authors Interest rank from 2001:

  • Local (Korean): #2181 in June 2021
  • Global: #89180 in March 2024

The highest popularity rank from 2008:

  • Local (Korean): #147637 in May 2024
  • Global: #313381 in July 2024

There are 4 language versions for this article in the WikiRank database (of the considered 55 Wikipedia language editions).

The quality and popularity assessment was based on Wikipédia dumps from July 1, 2025 (including revision history and pageviews for previous years).

The table below shows the language versions of the article with the highest quality.

Languages with the highest quality

#LanguageQuality gradeQuality score
1English (en)
Bictegravir/emtricitabine/tenofovir alafenamide
43.7754
2Chinese (zh)
比克替拉韦/恩曲他滨/丙酚替诺福韦
32.4441
3Korean (ko)
빅테그라비르/엠트리시타빈/테노포비르 알라페나미드
30.3326
4Arabic (ar)
بيكتارفي (دواء)
22.6966
More...

The following table shows the most popular language versions of the article.

Most popular in all the time

The most popular language versions of the article "빅테그라비르/엠트리시타빈/테노포비르 알라페나미드" in all the time
#LanguagePopularity awardRelative popularity
1English (en)
Bictegravir/emtricitabine/tenofovir alafenamide
194 666
2Chinese (zh)
比克替拉韦/恩曲他滨/丙酚替诺福韦
7 349
3Arabic (ar)
بيكتارفي (دواء)
3 490
4Korean (ko)
빅테그라비르/엠트리시타빈/테노포비르 알라페나미드
1 507
More...

The following table shows the language versions of the article with the highest popularity in the last month.

Most popular in June 2025

The most popular language versions of the article "빅테그라비르/엠트리시타빈/테노포비르 알라페나미드" in June 2025
#LanguagePopularity awardRelative popularity
1English (en)
Bictegravir/emtricitabine/tenofovir alafenamide
2 030
2Chinese (zh)
比克替拉韦/恩曲他滨/丙酚替诺福韦
366
3Arabic (ar)
بيكتارفي (دواء)
128
4Korean (ko)
빅테그라비르/엠트리시타빈/테노포비르 알라페나미드
52
More...

The following table shows the language versions of the article with the highest Authors’ Interest.

The highest AI

Language versions of the article "빅테그라비르/엠트리시타빈/테노포비르 알라페나미드" with the highest Authors Interest (number of authors). Only registered Wikipedia users were taken into account.
#LanguageAI awardRelative AI
1English (en)
Bictegravir/emtricitabine/tenofovir alafenamide
28
2Korean (ko)
빅테그라비르/엠트리시타빈/테노포비르 알라페나미드
6
3Chinese (zh)
比克替拉韦/恩曲他滨/丙酚替诺福韦
3
4Arabic (ar)
بيكتارفي (دواء)
2
More...

The following table shows the language versions of the article with the highest Authors’ Interest in the last month.

The highest AI in June 2025

Language versions of the article "빅테그라비르/엠트리시타빈/테노포비르 알라페나미드" with the highest AI in June 2025
#LanguageAI awardRelative AI
1Arabic (ar)
بيكتارفي (دواء)
0
2English (en)
Bictegravir/emtricitabine/tenofovir alafenamide
0
3Korean (ko)
빅테그라비르/엠트리시타빈/테노포비르 알라페나미드
0
4Chinese (zh)
比克替拉韦/恩曲他滨/丙酚替诺福韦
0
More...

The following table shows the language versions of the article with the highest number of citations.

The highest CI

Language versions of the article "빅테그라비르/엠트리시타빈/테노포비르 알라페나미드" with the highest Citation Index (CI)
#LanguageCI awardRelative CI
1English (en)
Bictegravir/emtricitabine/tenofovir alafenamide
142
2Korean (ko)
빅테그라비르/엠트리시타빈/테노포비르 알라페나미드
58
3Arabic (ar)
بيكتارفي (دواء)
32
4Chinese (zh)
比克替拉韦/恩曲他滨/丙酚替诺福韦
1
More...

Scores

Estimated value for Wikipedia:
Korean:
Global:
Popularity in June 2025:
Korean:
Global:
Popularity in all years:
Korean:
Global:
Authors in June 2025:
Korean:
Global:
Registered authors in all years:
Korean:
Global:
Citations:
Korean:
Global:

Quality measures

Interwikis

#LanguageValue
arArabic
بيكتارفي (دواء)
enEnglish
Bictegravir/emtricitabine/tenofovir alafenamide
koKorean
빅테그라비르/엠트리시타빈/테노포비르 알라페나미드
zhChinese
比克替拉韦/恩曲他滨/丙酚替诺福韦

Popularity rank trends

Best Rank Korean:
#147637
05.2024
Global:
#313381
07.2024

AI rank trends

Best Rank Korean:
#2181
06.2021
Global:
#89180
03.2024

Local AI rank history

Languages comparison

Important global interconnections (July 2024 – June 2025)

Wikipedia readers most often find their way to information on Bictegravir/emtricitabine/tenofovir alafenamide from Wikipedia articles about Gilead Sciences, Bictegravir, Tenofovir alafenamide, Integrase inhibitor and List of antiviral drugs. Whereas reading the article about Bictegravir/emtricitabine/tenofovir alafenamide people most often go to Wikipedia articles on Bictegravir, Tenofovir alafenamide, Emtricitabine, Antiretroviral therapy for HIV/AIDS and Reverse-transcriptase inhibitor.

Cumulative results of quality and popularity of the Wikipedia article

List of Wikipedia articles in different languages (starting with the most popular):

News from 12 August 2025

On 12 August 2025 in multilingual Wikipedia, Internet users most often read articles on the following topics: Cristiano Ronaldo, Wednesday, Georgina Rodríguez, ChatGPT, Weapons, Jenna Ortega, deaths in 2025, Taylor Swift, Miguel Uribe Turbay, 2025–26 UEFA Champions League.

In Korean Wikipedia the most popular articles on that day were: 문화방송, 김건희, 한국방송공사, 한국교육방송공사, 케이팝 데몬 헌터스, 윤미향, 유경촌, 노란봉투법, 윤석열, 강미정.

About WikiRank

The WikiRank project is intended for automatic relative evaluation of the articles in the various language versions of Wikipedia. At the moment the service allows to compare over 44 million Wikipedia articles in 55 languages. Quality scores of articles are based on Wikipedia dumps from July, 2025. When calculating current popularity and AI of articles data from June 2025 was taken into account. For historical values of popularity and AI WikiRank used data from 2001 to 2025... More information